Gregoriano, C., Molitor, A., Haag, E., Kutz, A., Koch, D., Haubitz, S., . . . Schuetz, P. (2021). Activation of Vasopressin System During COVID-19 is Associated With Adverse Clinical Outcomes: An Observational Study. J Endocr Soc.
Style de citation ChicagoGregoriano, Claudia, et al. "Activation of Vasopressin System During COVID-19 Is Associated With Adverse Clinical Outcomes: An Observational Study." J Endocr Soc 2021.
Style de citation MLAGregoriano, Claudia, et al. "Activation of Vasopressin System During COVID-19 Is Associated With Adverse Clinical Outcomes: An Observational Study." J Endocr Soc 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.